Time to Confirmatory Study Initiation After Accelerated Approval of Cancer and Noncancer Drugs in the US

被引：3
|
作者：
Jazowski, Shelley A. [1 ,5 ]
Vaidya, Avi U. [1 ]
Donohue, Julie M. [2 ]
Dusetzina, Stacie B. [1 ,3 ]
Sachs, Rachel E. [4 ]
机构：
[1] Vanderbilt Univ, Sch Med, Dept Hlth Policy, Nashville, TN USA
[2] Univ Pittsburgh, Sch Publ Hlth, Dept Hlth Policy & Management, Pittsburgh, PA USA
[3] Vanderbilt Ingram Canc Ctr, Nashville, TN USA
[4] Washington Univ St Louis, Sch Law, St Louis, MO USA
[5] Vanderbilt Univ, Sch Med, Dept Hlth Policy, 2525 West End Ave,Ste 1200, Nashville, TN 37203 USA
来源：
JAMA INTERNAL MEDICINE | 2023年 / 183卷 / 07期
基金：
美国医疗保健研究与质量局;
关键词：
D O I：
10.1001/jamainternmed.2023.0777
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
This cross-sectional study examines and compares the time taken from the accelerated approval of cancer and noncancer drugs to the initiation of confirmatory studies in the US.
引用
收藏
页码：737 / 739
页数：3
相关论文
共 50 条
  • [1] Accelerated Approval Of Cancer Drugs: No Economic Reward For Drug Makers That Conduct Confirmatory Trials
    Frank, Richard G.
    Shahzad, Mahnum
    Emanuel, Ezekiel J.
    HEALTH AFFAIRS, 2022, 41 (09) : 1273 - 1280
  • [2] Exposure to US Cancer Drugs With Lack of Confirmed Benefit After US Food and Drug Administration Accelerated Approval
    Parikh, Ravi B. B.
    Hubbard, Rebecca A. A.
    Wang, Erkuan
    Royce, Trevor J. J.
    Cohen, Aaron B. B.
    Clark, Amy S. S.
    Mamtani, Ronac
    JAMA ONCOLOGY, 2023, 9 (04) : 567 - 569
  • [3] Global consequences of the US FDA's accelerated approval of cancer drugs
    Akhade, Amol
    Sirohi, Bhawna
    Gyawali, Bishal
    LANCET ONCOLOGY, 2022, 23 (02): : 201 - 203
  • [4] Confirmatory Trials of Accelerated Approval Drugs - Will Imposing Fines Reduce Delays?
    Daval, C. Joseph Ross
    Kesselheim, Aaron S.
    Scheffer Cliff, Edward R.
    NEW ENGLAND JOURNAL OF MEDICINE, 2024,
  • [5] Regulatory and clinical consequences of negative confirmatory trials of accelerated approval cancer drugs: retrospective obser-vational study
    Gyawali, Bishal
    Rome, Benjamin N.
    Kesselheim, Aaron S.
    BMJ-BRITISH MEDICAL JOURNAL, 2021, 374
  • [6] Impact of the US Accelerated Approval for New Anticancer Drugs on Time to Verification of Benefit and Regulatory Approval in the EU and Japan
    Akira Ito
    Mamoru Narukawa
    Therapeutic Innovation & Regulatory Science, 2024, 58 : 136 - 142
  • [7] Accelerated approval scrutinized - Confirmatory phase 4 studies on new drugs languish
    Mitka, M
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2003, 289 (24): : 3227 - 3229
  • [8] Impact of the US Accelerated Approval for New Anticancer Drugs on Time to Verification of Benefit and Regulatory Approval in the EU and Japan
    Ito, Akira
    Narukawa, Mamoru
    THERAPEUTIC INNOVATION & REGULATORY SCIENCE, 2024, 58 (01) : 136 - 142
  • [9] Association Between Preapproval Confirmatory Trial Initiation and Conversion to Traditional Approval or Withdrawal in the FDA Accelerated Approval Pathway
    Shahzad, Mahnum
    Naci, Huseyin
    Wagner, Anita K.
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2023, 329 (09): : 760 - 761
  • [10] Accelerated Approval of Cancer Drugs-Righting the Ship of the US Food and Drug Administration
    DiMagno, Sarah S. P.
    Glickman, Aaron
    Emanuel, Ezekiel J.
    JAMA INTERNAL MEDICINE, 2019, 179 (07) : 922 - 923
12345